key: cord-0064630-cgihixvn authors: Diriba, Kuma; Awulachew, Ephrem; Gemede, Aschelew; Anja, Asrat title: The magnitude of extended-spectrum beta-lactamase- producing Enterobacteriaceae from clinical samples in Ethiopia: a systematic review and meta-analysis date: 2021-01-28 journal: Access Microbiol DOI: 10.1099/acmi.0.000195 sha: 8761c0fc9024d86629890780ceef8c4a9ab5d26d doc_id: 64630 cord_uid: cgihixvn BACKGROUND: The rapid spread of resistance among extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae is a serious problem around the world. It results in serious clinical complications in humans and has become a global threat. Therefore, this systematic review and meta-analysis was aimed to estimate the pooled prevalence of ESBL-producing Enterobacteriaceae in different clinical samples in Ethiopia. METHODS: A systematic search was conducted on PubMed, Web of Science, Embase, Google Scholar and the Cochrane Library. All identified observational studies reporting the prevalence of ESBL-producing Enterobacteriaceae from clinical samples in Ethiopia were included. Four authors independently extracted data and analysed using R software version 3.6.1 and STATA statistical software version 13. A random-effects model was computed to estimate the pooled prevalence of ESBL-producing Enterobacteriaceae in Ethiopia. RESULTS: Of 142 articles reviewed, 14 studies that fulfilled the inclusion criteria were included in the meta-analysis. The pooled prevalence of ESBL-producing Enterobacteriaceae in the different clinical specimens in Ethiopia was 49 % (95 % CI: 39, 60). Klebsiella pneumoniae was the leading ESBL-producing Enterobacteriaceae followed by Escherichia coli and Acinetobacter baumannii with a prevalence of 74, 67 and 60 %, respectively. ESBL-producing isolates showed a high rate of resistance to cefotaxime, ceftriaxone, ceftazidime, Amoxicillin clavulanic acid (AMC), ampicillin and aztreonam. The better options for the treatment of ESBL-producing Enterobacteriaceae are amikacin and Imipenem. CONCLUSION: The magnitude of ESBL-producing Enterobacteriaceae in different clinical samples in Ethiopia is alarmingly high and represents a threat to human health. Hence, a coordinated effort needs to be implemented for the prevention and control of these Enterobacteriaceae . Enterobacteriaceae are a huge, heterogeneous group of gram-negative rods whose natural habitat is the intestinal tract of humans and animals [1] . These microorganisms have emerged as one of the most important reasons for nosocomial and community-obtained infections [2] [3] [4] [5] . Enterobacteriaceae are typically associated with a range of infections [6] , among which urinary tract infections, bloodstream infections, heath facility-associated pneumonia and some intra-abdominal infections are the most crucial [7, 8] . Studies conducted in different underdeveloped countries indicate a high case fatality rate associated with bloodstream infection, due to Enterobacteriaceae [9, 10] . Antibiotics play a vital role in decreasing the load of communicable diseases worldwide [11] . Microbial resistance to antimicrobial agents is rising remarkably worldwide [12] [13] [14] . This rapid spread of resistance among pathogenic microorganisms is a serious problem globally [2, 4] , because it limits drug treatment against infections OPEN ACCESS [15] . Antimicrobial resistance has been recognized as one of the most important problems facing human health by the World Health Organization (WHO) [15, 16] . Frequent isolation of multidrug resistant (MDR) pathogens in both hospital and community-acquired infections has further intensified the problem of antimicrobial resistance [5] . Currently, extended-spectrum β-lactamase (ESBL)producing Enterobacteriaceae represent a serious public health issue globally [1] . They become resistant to betalactam antibiotics via the production of beta-lactamase enzymes that inactivate beta-lactam antibiotics, and this continues to be the prominent cause of β-lactam antibiotic resistance among Enterobacteriaceae [17, 18] . They can rapidly develop resistance against a range of important broad-spectrum antimicrobials [19, 20] . Inappropriate and irrational use of antimicrobial drugs, and poor sanitary and infection control practices in the area may play a critical role in the increased prevalence of resistant bacteria in a community, providing favourable conditions for resistant microorganisms to emerge and spread [21, 22] . This can lead to a proliferation of organisms with broad-spectrum β-lactamase activity that threatens the future of the β-lactam class in clinical care [21] . The increasing rate of human infections caused by antimicrobial resistance strains of Enterobacteriaceae makes clinical management more difficult by prolonging the illness and compromising treatment [5] . This can have a potentially serious impact on human health. The situation is more common in developing countries where there is widespread and uncontrolled use of antibiotics [16] . Data on ESBL-producing Enterobacteriaceae in Ethiopia are limited and are not currently available in aggregate form. Therefore, this systematic review and meta-analysis aimed to determine the pooled prevalence of ESBL-producing Enterobacteriaceae using available studies in Ethiopia. A systematic review and meta-analysis was conducted to estimate the prevalence of ESBL-producing Enterobacteriaceae from clinical samples from patients attending health institutions in Ethiopia following the methodological framework suggested by Arksey and O'Malley [23] . All relevant articles were searched without date limits using the following databases: PubMed, Web of Science, Embase, Google Scholar, Cochrane Library and Science Direct according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) [24] . All searches were limited to articles written in English given that such language restriction does not alter the outcome of the systematic reviews and meta-analysis [25] . Grey literature of observational studies was searched through the review of reference lists and input of content experts. The search of the literature was conducted from May 2005 to September 2019. All papers published until the end of 2019 that fulfilled the inclusion criteria were considered. The search used the following keywords: 'Extended-spectrum β-lactamase; β-lactams resistance; antibiotic resistance; Enterobacteriaceae; K. pneumoniae; E. coli; Ethiopia' . We searched all terms with the help of Boolean operators such as ' AND' or 'OR' . Studies conducted in Ethiopia and articles reported in English were considered. Only studies involving humans and published articles were included. All observational study designs reporting data regarding the proportion of ESBL-producing Enterobacteriaceae isolated from humans were eligible for this review. Studies with the following characteristics were excluded from the analysis: review articles, letters, articles that had no original data, articles that did not identify the species and the origin of isolates, articles that were not fully accessible, performed outside Ethiopia, duplicate publications of the same study and studies involving animals. Studies selected for inclusion were assessed for methodological quality by all authors independently using the standard critical appraisal instruments of the Joanna Briggs Institute Meta-Analysis of Statistics Assessment for Review Instrument (JBI-MAStARI) [26] . Disagreements were resolved by consensus The primary outcome variable of this study was the prevalence of ESBL-producing Enterobacteriaceae, while the secondary outcome was the antibiotics resistance profile of ESBL-producing Enterobacteriaceae. The data were extracted using a standardized data extraction format, adapted from the Joanna Briggs Institute (JBI), by three authors (Kuma Diriba, Asrat Anja and Ephrem Awulachew) independently extracting all necessary data. The extracted data were then merged for systematic analysis. Any disagreements during the data extraction were resolved through discussion and consensus. The main outcomes extracted from the study were: primary author, publication year, study method, study area, sample size and cases. Data on associated risk factors were also extracted by the authors. Following data extraction, systematic review and metaanalysis were carried out using R software version 3.6.1 and STATA statistical software (version 13) with user-contributed commands for meta-analyses: metaprop, metan, metainf, metabias and metareg [27] . The effect sizes and SEs of the studies were pooled using a random-effects model to calculate the pooled prevalence of ESBL-producing Enterobacteriaceae in different clinical samples in Ethiopia. A meta-analysis was also planned to assess the antibiotic resistance profile of ESBL-producing Enterobacteriaceae. The standard error for each original study was calculated using the binomial distribution formula. Evidence for statistical heterogeneity among reported prevalence was using the Cochrane Q-test and I 2 statistics [28] . The pooled proportion was estimated by using the back-transform of the weighted mean of the transformed proportions for both the fixed-effects model and the random-effects model [29] . A significance level of P<0.10 and I 2 >50 % was interpreted as evidence of heterogeneity [30] . A potential source of heterogeneity was investigated by subgroup analysis and meta-regression analysis [31] . Where statistical pooling was not possible, the findings were presented in a narrative form including tables and figures to aid in data presentation where appropriate. Sensitivity analyses were conducted to determine the relative influence of each individual study on the pooled effect size using a user-written function, metainf. The presence of publication bias was assessed informally by visual inspection of funnel plots [32] . Point prevalence, as well as 95 % confidence intervals, was presented in the forest plot format. The database searches identified a total of 142 articles reporting the prevalence of ESBL-producing Enterobacteriaceae in different clinical samples using the range of databases previously described. From these initial articles, 63 were excluded due to duplication. From the remaining 79 articles, 39 were excluded after review of their titles and abstracts confirmed non-relevance to this review, 40 articles were assessed with respect to their eligibility for inclusion, which resulted in the further exclusion of 26 articles primarily due to the study being done in other countries , and 14 studies were included in the final systematic review and meta-analysis (Fig. 1) . In this review, 14 Table 1) . A risk of bias tool [63] was used to assess the risk of bias for the included studies and >90 % of the studies had a low risk of bias. In almost all studies, different clinical samples were collected from patients who attended different health institutions. All Enterobacteriaceae were screened for ESBL production using cefotaxime and ceftazidime, and doubledisc synergy methods were used for detection of ESBLproducing strains in almost all of the studies. The pooled prevalence of ESBL-producing Enterobacteriaceae in different clinical specimen in Ethiopia was 49 % (95 % CI: 39, 60) . Due to the presence of high heterogeneity (I 2 =62, P<0.01), a random effect meta-analysis model was explored to assess the pooled prevalence of Campylobacter species in children less than 5 years old in Ethiopia (Fig. 2) . To identify sources of heterogeneity, we assessed the year when the study was published, study area and sample size using univariate meta-regression models, but all were statistically non-significant for the included study (Table 2) . A funnel plot showed an irregular distribution of the articles. In the current study, subgroup analysis was done based on the area where the study was performed. Based on subgroup analysis, the distribution of ESBL-producing Enterobacteriaceae throughout the country varied from region to region. A high prevalence of ESBL-producing Enterobacteriaceae was reported in Addis Ababa followed by SNNPR, with a prevalence of 63.5 and 58 %, respectively ( Table 3 ). In this study, we tried to assess the prevalence of ESBLproducing Enterobacteriaceae in different clinical specimen collected from patients. About 1962 Enterobacteriaceae among 11 species were collected from 14 studies conducted in Ethiopia. Klebsiella pneumoniae was the leading ESBLproducing Enterobacteriaceae followed by Escherichia coli and Acinetobacter baumannii with prevalences of 74, 67 and 60%, respectively. Proteus species were the least frequent ESBL-producing Enterobacteriaceae with a prevalence of 17 % (Fig. 3) . In the present study, ESBL-producing Enterobacteriaceae were found predominantly in blood specimens (62.3 %), followed by urine specimens (41.2 %) and wounds (35 %) . Based on the data collected from the included studies, none of the ESBLproducing Enterobacteriaceae was isolated from body fluid, nasal swab or sputum sample (0 %) ( Table 4 ) In the present systematic review and meta-analysis, ESBL-producing isolates were highly resistant to both third-generation cephalosporins and non-beta lactam antimicrobial agents. Higher resistance rates were recorded among cefotaxime, ceftriaxone, amoxacillin clauvilic acid, ampicillin and aztreonam with values of >90 % ( Table 5 ). The resistance rates of ESBL-producing isolates to ceftazidime, tetracycline, SXT and chloramphenicol were 77-89 %. However, amikacin and impenem showed greater efficacy against ESBL-producing Enterobacteriaceae with efficacy rates of 84-97 % ( Table 5 ). Data on the magnitude of ESBL-producing Enterobacteriaceae in different clinical samples collected from different studies conducted in Ethiopia are limited and are not currently available in aggregated form. The emergence and rapid spread of multidrug resistance strains of ESBL-producing Enterobacteriaceae is a serious public health issue worldwide. Rapid expansion of ESBLs is greatly affecting the activity of broadspectrum antibiotics, creating major therapeutic difficulties with a significant impact on patient outcomes [64] . The phenotypic information obtained in the current metaanalysis indicates a significant prevalence of ESBL producers. The overall magnitude of ESBL-producing Enterobacteriaceae in different clinical samples obtained from this study was 49 %, indicating a remarkable health problems in developing and developed countries [65] . Our finding is consistent with studies conducted in Tanzania [66] , Nigeria [43] , Burkina Faso [67] and Ghana [68] with prevalence ranging from 44 to 58 %. However, it is higher than for studies conducted in Italy [69] , Egypt [70] and Turkey [71] with prevalence ranging from 0.5 to 24 % respectively. This variation might be explained by methodological differences, differences in study area and quality of media used. The use of low-quality antibiotics, inappropriate use of antibiotics, and weak infection prevention measures may additionally contribute to the high prevalence of ESBLs. Based on this meta-analysis, K. pneumonia was the leading ESBL-producing Enterobacteriaceae with a prevalence of 74 %, followed by E. coli (67 %) and A. baumannii (60 %) . This was in agreement with studies conducted in Uganda [72] with . Rapid adaptation to selective changes in environmental pressures, upregulation of the intrinsic resistance mechanisms, and acquisition and transfer of drug resistance genes through mobile genetic elements such as plasmids and transposons could be a possible explanation for an elevated overall drug resistance prevalence rate against different categories of drugs. In the present study, a high prevalence of ESBL-producing Enterobacteriaceae was found in blood specimens (62.3 %), followed by urine specimens (41.2 %) and wounds (35 % 16 .5 % in blood) and central India [79] (52.28 % in urine) reported urine specimens as the major source of ESBL-producing Enterobacteriaceae. This indicates that ESBL-producing Enterobacteriaceae are becoming a serious problem in the treatment of invasive bacterial infections. In this meta-analysis, ESBL-producing Enterobacteriaceae were highly resistant to ampicillin, followed by cefotaxime, aztreonam, AMC and ceftazidime, with resistance rates ranging from 88 to 100 %, while the lowest resistance was found against amikacin and impenem, 3-16 %. Our finding agrees with studies conducted in Burkina Faso [67] , Ghana [68] , Saudi Arabia [80] , Israel [81] , Poland [82] and Sierra Leone [83] . This indicates that ESBL-producing Enterobacteriaceae were rapidly emerging in developing countries. In this meta-analysis, ESBL-producing Enterobacteriaceae were resistant not only to third-generation cephalosporins but also to other non-β lactam group antibiotics. The findings of this meta-analysis showed that amikacin and impenem had better performance against ESBL-producing Enterobacteriaceae than other antibiotics, including cephalosporins. Moges and colleagues [84] also reported that amikacin and imipenem performed better in the treatment of ESBL-producing Enterobacteriaceae. The multidrug resistance nature of ESBL-producing Enterobacteriaceae may be explained by the fact that they are plasmid-mediated enzymes that carry multiresistance genes by plasmids, transposons and integrons, and also that they are readily transferred to other bacteria through conjugation, transduction or transformation. Those bacteria may not necessarily be of the same species. Bacteria with multiple resistance to antibiotics are now widely distributed in hospitals, are increasingly being isolated from community settings and have become a serious problem throughout the world AMC, amoxicillin-clavulanic acid; C, chloramphicol; SXT, trimethoprim-sulphamethoxazole. [85] . This is the most challenging and alarming condition in the management of infectious diseases associated with ESBLproducing Entrobacteriaceae. The articles for this study were limited to the English language. With the study method (most of them were cross-sectional), this can affect the outcome variable by other confounding variables. Additionally, the small sample size could affect the estimated pooled prevalence of ESBLproducing Enterobacteriaceae. This meta-analysis represented studies reported from a limited study area, which may reflect under-representation due to the limited number of studies included. The authors of the primary studies did not mention or characterize whether the isolates studied were hospital-acquired or community-based. This may be the source for the outcome of the study. Furthermore, differences in the methods used to characterize the bacterial isolates may also affect the estimated outcome. In this meta-analysis, there was a high prevalence of ESBLproducing Enterobacteriaceae, which might contribute to the occurrence of multidrug resistance. Most ESBL-producing isolates were found primarily in blood and urine specimens. The most frequent ESBL-producing Enterobacteriaceae were K. pneumoniae, E. coli and A. baumannii. ESBL-producing isolates showed a high rate of resistance to cefotaxime, ceftriaxone, ceftazidime, AMC, ampicillin and aztreonam. The best options for the treatment of ESBL-producing Enterobacteriaceae are amikacin and impenem. The rise of ESBL-producing Enterobacteriaceae requires strict infection prevention and control strategies and strengthening of diagnostic capacity of laboratory professionals for the detection and surveillance of antibiotic resistance. All data relevant to the study are included in the article or have been uploaded as online supplementary information. The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. Clinical impact of gram-negative nonfermenters on adults with community-onset bacteremia in the emergency department The antibiotic resistance crisis: Part 1: causes and threats The state of the world's antibiotics 2015 Non-carbapenem therapy of urinary tract infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae Antibiotic resistance threats in the United States Emerging issues regarding management of MDR non-fermenting gram negative ventilator associated pneumonia in a rural catering tertiary care hospital Global spread of carbapenemaseproducing Enterobacteriaceae Resistance in gram-negative bacteria: Enterobacteriaceae Atr-Ftir spectroscopy reveals genomic loci regulating the tissue response in high fat diet fed bxd recombinant inbred mouse strains Risk and causes of paediatric hospital-acquired bacteraemia in Kilifi district Hospital, Kenya: a prospective cohort study Extended-spectrum β-lactamase-and carbapenemase-producing Enterobacteriaceae isolated from Egyptian patients with suspected blood stream infection Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones Priority Medicines for Europe and the World a Public Health Approach to Innovation, 6. WHO Background Paper The epidemiology and control of Acinetobacter baumannii in health care facilities New Treatment Options Against Gram-Negative Organisms. SpringerAnnual Update in Intensive Care and Emergency Medicine Extended-spectrum β-lactamases: a clinical update Extended-Spectrum β-lactamaseproducing Enterobacteriaceae: an emerging public-health concern Global forecast of antimicrobial resistance in invasive isolates of Escherichia coli and Klebsiella pneumoniae The contribution of extended-spectrum β-lactamases to multidrug-resistant infections in children Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype Updated functional classification of β-lactamases Scoping studies: towards a methodological framework The PRISMA statement for reporting systematic reviews and metaanalyses of studies that evaluate health care interventions: explanation and elaboration The inclusion of reports of randomised trials published in languages other than English in systematic reviews Systematic Reviews of Health Promotion and Public Health Interventions. Melbourne: University of Melbourne Clinical features and chest CT manifestations of coronavirus disease 2019 (COVID-19) in a single Undue reliance on I 2 in assessing heterogeneity may mislead Metaprop: a Stata command to perform meta-analysis of binomial data Explaining heterogeneity in meta-analysis: a comparison of methods The comparison of percentages in matched samples Bias in meta-analysis detected by a simple, graphical test Prevalence and antibiogram of extended spectrum β-lactamase (ESBL) producing gram negative bacilli and further molecular characterization of ESBL producing Escherichia coli and Klebsiella spp Urinary tract infections due to extended-spectrum beta-lactamase-producing gram-negative bacteria: identification of risk factors and outcome predictors in an Australian tertiary referral hospital Multi-drug resistance and extended spectrum beta lactamase producing gram negative bacteria from chicken meat in Bharatpur metropolitan Antimicrobial susceptibility pattern of extended spectrum beta-lactamase producing gram-negative bacteria isolated from wound and urine in a tertiary care Hospital, Dhaka City Clinical outcomes with ertapenem as a first-line treatment option of infections caused by extendedspectrum β-lactamase producing gram-negative bacteria An observational study on bloodstream extended-spectrum beta-lactamase infection in critical care unit: incidence, risk factors and its impact on outcome Prevalence of extended-spectrum beta-lactamase-producing gram-negative bacilli and emergence of mcr-1 colistin resistance gene in Lebanese swine farms Extended-Spectrum beta-lactamase producing gram negative bacteria in Iran: a review Prevalence of multidrug resistant and extended spectrum betalactamase producing Pseudomonas aeruginosa in a tertiary care hospital The role of horizontal gene transfer in the dissemination of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in an endemic setting Extended-spectrum beta-lactamase (ESBL)-producing Gram-negative isolates from urine and wound specimens in a tertiary health facility in southern Nigeria Characterization of multidrug resistant extended-spectrum betalactamase-producing Escherichia coli among uropathogens of pediatrics in North of Iran Editorial commentary: bloodstream infection caused by extended-spectrum β-Lactamase-Producing gramnegative bacteria: how to define the best treatment regimen? Extended-Spectrum beta-lactamase bacteria from urine isolates in children Rate of transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae without contact isolation TEM mediated extended spectrum cephalosporin resistance in clinical & environmental isolates of Gram negative bacilli: A report from northeast India Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy The prevalence of TEM and SHV genes among extended-spectrum beta-lactamases producing Escherichia coli and Klebsiella pneumoniae Gram-negative bacilli recovered from patients and specimens referred to national reference laboratory High gastrointestinal colonization rate with extended-spectrum β-lactamase-producing Enterobacteriaceae in hospitalized patients: emergence of carbapenemase-producing K. pneumoniae in Ethiopia Isolation of extended-spectrum β-lactamase-(ESBL-) producing Escherichia coli and Klebsiella pneumoniae from patients with community-onset urinary tract infections in Jimma University Specialized Hospital, Southwest Ethiopia Emergence of high drug resistant bacterial isolates from patients with health care associated infections at Jimma University medical center: a cross sectional study Prevalence and antibiotic susceptibility pattern of CTX-M type extendedspectrum β-lactamases among clinical isolates of gram-negative bacilli in Jimma Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement The continuing plague of extendedspectrum β-lactamase-producing Enterobacteriaceae infections Rapid emergence of ESBL producers in E. coli causing urinary and wound infections in Pakistan Antimicrobial resistance among producers and non-producers of extended spectrum beta-lactamases in urinary isolates at a tertiary hospital in Tanzania High prevalence of extended-spectrum ß-lactamase producing Enterobacteriaceae among clinical isolates in Burkina Faso High levels of extended-spectrum beta-lactamases in a major teaching hospital in Ghana: the need for regular monitoring and evaluation of antibiotic resistance Extended-Spectrum beta-lactamases producing Escherichia coli and Klebsiella pneumoniae: a multi-centric study across Karnataka CTX-M-15-producing Escherichia coli clinical isolates in Cairo (Egypt), including isolates of clonal complex ST10 and clones ST131, ST73, and ST405 in both community and hospital settings Beta-Lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates Phenotypic expression and prevalence of ESBL-producing Enterobacteriaceae in samples collected from patients in various wards of Mulago Hospital Extended-Spectrum beta (β)-lactamases and Antibiogram in Enterobacteriaceae from clinical and drinking water Sources from Bahir Dar City Phenotypic and Genotypic Characterization of ESBL-Producing Escherichia coli and Klebsiella pneumonia isolates from Patient's Urine specimens Prevalence of multiple drug resistant clinical isolates of extended-spectrum beta-lactamase producing Enterobacteriaceae in Southeast Iran Antimicrobial susceptibility profile of extended spectrum β-lactamase (ESBL) producing Escherichia coli from various clinical samples Prevalence and antimicrobial susceptibility of extended spectrum β-lactamases (ESBL) producing Escherichia coli and Klebsiella pneumoniae isolates in a tertiary care hospital in north-west India Antibiogram of extended spectrum betalactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae isolated from hospital samples Phenotypic determination of ESBL-and Ampc-producing Enterobacteriaceae in cheese samples The occurrence of ESBL-producing Escherichia coli carrying aminoglycoside resistance genes in urinary tract infections in Saudi Arabia High levels of antimicrobial coresistance among extended-spectrumbeta-lactamase-producing Enterobacteriaceae Antibiotic resistance in soil and water environments High prevalence of multidrug resistant Enterobacteriaceae isolated from outpatient urine samples but not the hospital environment in bo High prevalence of extended-spectrum beta-lactamase-producing gram-negative pathogens from patients attending Felege Hiwot comprehensive specialized Hospital More extended-spectrum betalactamases Extended-spectrum beta-lactamase production and multidrug resistance among Enterobacteriaceae isolated in Addis Ababa Extended spectrum and metalo beta-lactamase producing airborne Pseudomonas aeruginosa and Acinetobacter baumanii in restricted settings of a referral hospital: a neglected condition Genetic markers associated with resistance to beta-lactam and quinolone antimicrobials in non-typhoidal Salmonella isolates from humans and animals in central Ethiopia The authors would like to acknowledge the authors of the primary studies and Dilla University, Collage of Health Science and Medicine and Department of Medical Laboratory Science. The authors declare that there are no conflicts of interest. Ethical approval was not required because the analysis under consideration is from data already publicly available in published studies.